Comment on "An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology"
- PMID: 33744352
- PMCID: PMC7965843
- DOI: 10.1016/j.jaad.2021.03.038
Comment on "An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology"
Conflict of interest statement
Conflicts of interest None disclosed.
Figures
Comment in
-
Response to comment on "An evidence-based guide to SARS-Cov-2 vaccination of patients on immunotherapies in dermatology.".J Am Acad Dermatol. 2021 Aug;85(2):e91. doi: 10.1016/j.jaad.2021.04.026. Epub 2021 Apr 17. J Am Acad Dermatol. 2021. PMID: 33878412 Free PMC article. No abstract available.
Comment on
-
An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology.J Am Acad Dermatol. 2021 Jun;84(6):1652-1666. doi: 10.1016/j.jaad.2021.01.047. Epub 2021 Jan 19. J Am Acad Dermatol. 2021. PMID: 33482251 Free PMC article. Review.
References
-
- Kim W., Kim S.-H., Huh S.-Y., et al. Reduced antibody formation after influenza vaccination in patients with neuromyelitis optica spectrum disorder treated with rituximab. Eur J Neurol. 2013;20(6):975–980. - PubMed
-
- Oliveira A.C.V., Mota L.M.H., Santos-Neto L.L., Simões M., Martins-Filho O.A., Tauil P.L. Seroconversion in patients with rheumatic diseases treated with immunomodulators or immunosuppressants, who were inadvertently revaccinated against yellow fever. Arthritis Rheumatol. 2015;67(2):582–583. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
